Kennedy Capital Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$947K Buy
14,361
+1,178
+9% +$74.9K 0.02% 492
2025
Q4
$838K Buy
13,183
+162
+1% +$10.1K 0.02% 495
2025
Q3
$716K Buy
13,021
+6,350
+95% +$262K 0.02% 519
2025
Q2
$220K Buy
6,671
+165
+3% +$5.74K 0.01% 563
2025
Q1
$261K Buy
6,506
+83
+1% +$3.81K 0.01% 614
2024
Q4
$302K Buy
6,423
+1,172
+22% +$60.9K 0.01% 649
2024
Q3
$277K Buy
5,251
+755
+17% +$42.1K 0.01% 663
2024
Q2
$244K Buy
4,496
+1,304
+41% +$78.7K 0.01% 674
2024
Q1
$224K Buy
+3,192
New +$247K ﹤0.01% 697
2015
Q4
Sell
-348,701
Closed -$2.33M 735
2015
Q3
$2.33M Buy
+348,701
New +$2.38M 0.05% 544

Other funds holding CYTK